CONDENSED CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating revenues (net of contractual allowances)	$ 29,172	$ 29,556
Less provision for bad debts of Healthcare Facilities Segment	3,482	3,379
Net revenues	25,690	26,177
Costs and Expenses
Cost of goods sold	4,237	4,934
Salaries, wages and benefits	13,221	13,133
Provision for bad debts of Specialty Pharmacy Segment	80	270
Supplies	2,263	2,191
Purchased services	1,956	2,065
Other operating expenses	4,105	4,076
Rent and lease expense	546	577
Impairment of property, plant and equipment	789	0
Depreciation and amortization	984	1,099
Medicaid Electronic Health Records incentive payments	0	(659)
Operating loss	(2,491)	(1,509)
Other Income (Expense):
Interest expense	(559)	(1,303)
Interest income	0	2
Loss from Continuing Operations before income taxes	(3,050)	(2,810)
Income Tax Benefit	(1,428)	(1,067)
Loss from Continuing Operations	(1,622)	(1,743)
Earnings from Discontinued Operations, net of taxes	198	188
Net Loss	(1,424)	(1,555)
Other comprehensive income	0	0
Comprehensive loss	$ (1,424)	$ (1,555)
Continuing Operations:
Basic	$ (0.17)	$ (0.20)
Diluted	$ (0.17)	$ (0.20)
Discontinued Operations:
Basic	$ 0.02	$ 0.02
Diluted	$ 0.02	$ 0.02
Net Loss:
Basic	$ (0.15)	$ (0.18)
Diluted	$ (0.15)	$ (0.18)
Weighted-Average Common Shares Outstanding:
Basic	9,446	8,581
Diluted	9,446	8,581